CTLA-4 (Ipilimumab biosimilar) Antibody from ICHORBIO

Search, find, compare suppliers for anti-CTLA-4 (Ipilimumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCTLA-4 (Ipilimumab biosimilar)
Clonemonoclonal
Host SpeciesHumanized
Reactive Specieshuman
IsotypeIgG1 kappa
FormatProtein A/G purified, low endotoxin
Size10mg
Concentration1.0 - 5.0 mg/ml
ApplicationsRUO
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSpecificity: detects human CTLA-4. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Ipilimumab. Ipilimumab biosimilar is a recombinant, human monoclonal antibody that binds to the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4). Ipilimumab biosimilar is an IgG1 kappa immunoglobulin with an approximate molecular weight of 148 kDa. Ipilimumab biosimilar is produced in mammalian (Chinese hamster ovary) cell culture.
Immunogenn/a
Other NamesCtla4, Cytotoxic T-lymphocyte protein 4, CD152
Gene, Accession #UniProt: P16410
Catalog #ICH4025-10mg
Price$1145
Order / More InfoCTLA-4 (Ipilimumab biosimilar) Antibody from ICHORBIO
Product Specific Referencesn/a
ICHORBIO
ICHORBIO
ICHORBIO
Boston House, Grove Business Park
Downsview Road
Wantage OX12 9FF ENGLAND

orders@ichor.bio

https://ichor.bio

U.S. OFFICE
987 Old Eagle School Rd, Ste 709
Wayne, PA 19087
us@ichor.bio


Profile of ICHORBIO
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.